Dr. Fabian Pitter Steinmetz is a German, Eurotox-certified toxicologist who works at the international consultancy Delphic HSE. After some experiences in the pharmaceutical industry, he completed his PhD in predictive toxicology at Liverpool John Moores University in 2016. Scientifically, he is interested in quantitative structure-activity relationships, novel psychoactive substances but also in regulatory approaches to reduce harm. In this context, he is active in several national and international organisations advocating for drug policy reform, for example, as a scientific advisor for the European Kratom Alliance.

Dr. Oliver Grundmann is a clinical professor at the University of Florida, College of Pharmacy. He serves as the director of the graduate programs in Pharmaceutical Chemistry and Clinical Toxicology, is a fellow of the American College of Clinical Pharmacology, and his primary research interest is centered on the neuropharmacology of natural products, especially substances with potential for tolerance and dependence development. Dr. Grundmann obtained his BS in Pharmacy from the Westfälische-Wilhelms-Universität Münster in Germany, his PhD in Pharmaceutical Sciences, MS in Forensic Toxicology, and MEd from the University of Florida. He has been teaching on the subject of natural products, drug abuse, forensic & clinical toxicology, and pharmaceutical sciences for the past 15 years.